124 related articles for article (PubMed ID: 8535222)
1. Expression of N-CAM (CD56) on acute leukemia cells: relationship with disease characteristics and outcome.
Thomas X; Vila L; Campos L; Sabido O; Archimbaud E
Leuk Lymphoma; 1995 Oct; 19(3-4):295-300. PubMed ID: 8535222
[TBL] [Abstract][Full Text] [Related]
2. The expression pattern of CD56 (N-CAM) in human bone marrow biopsies infiltrated by acute leukemia.
Khanlari B; Buser A; Lugli A; Tichelli A; Dirnhofer S
Leuk Lymphoma; 2003 Dec; 44(12):2055-9. PubMed ID: 14959847
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0.
Suzuki R; Murata M; Kami M; Ohtake S; Asou N; Kodera Y; Tomonaga M; Masaki Y; Kusumoto S; Takeuchi J; Matsuda S; Hirai H; Yorimitsu mS; Hamajima N; Seto M; Shimoyama M; Ohno R; Morishima Y; Nakamura S
Int J Hematol; 2003 Jun; 77(5):482-9. PubMed ID: 12841387
[TBL] [Abstract][Full Text] [Related]
4. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
[TBL] [Abstract][Full Text] [Related]
5. CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.
Raspadori D; Damiani D; Michieli M; Stocchi R; Gentili S; Gozzetti A; Masolini P; Michelutti A; Geromin A; Fanin R; Lauria F
Haematologica; 2002 Nov; 87(11):1135-40. PubMed ID: 12414342
[TBL] [Abstract][Full Text] [Related]
6. [Expression of CD56 in acute leukemia and its clinical significance].
Zhang Y; Tang YM; Yang SL; Shen HQ; Qian BQ; Song H; Shi SW; Xu WQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):187-90. PubMed ID: 12513782
[TBL] [Abstract][Full Text] [Related]
7. [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry].
Xu B; Hu C; Miao XD; Wu YH; Yi ZS; Yang Y; Meng FY; Feng R; Liu QF; Liu XL; Zheng WY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1043-6. PubMed ID: 14559689
[TBL] [Abstract][Full Text] [Related]
8. The importance of CD7 and CD56 antigens in acute leukaemias.
Tiftik N; Bolaman Z; Batun S; Ayyildiz O; Isikdogan A; Kadikoylu G; Muftuoglu E
Int J Clin Pract; 2004 Feb; 58(2):149-52. PubMed ID: 15055863
[TBL] [Abstract][Full Text] [Related]
9. CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis.
Raspadori D; Damiani D; Lenoci M; Rondelli D; Testoni N; Nardi G; Sestigiani C; Mariotti C; Birtolo S; Tozzi M; Lauria F
Leukemia; 2001 Aug; 15(8):1161-4. PubMed ID: 11480556
[TBL] [Abstract][Full Text] [Related]
10. [Immunophenotypic Analysis of Patients with CD56⁺ Acute Myeloid Leukemia].
Guo R; Shen AL; Wang Y; Liu L; Zhang JF; Wang R; Li JY; Wu YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1231-4. PubMed ID: 26524014
[TBL] [Abstract][Full Text] [Related]
11. Role of FAB classification of acute leukemias in era of immunophenotyping.
Sachdeva MU; Ahluwalia J; Das R; Varma N; Garewal G
Indian J Pathol Microbiol; 2006 Oct; 49(4):524-7. PubMed ID: 17183842
[TBL] [Abstract][Full Text] [Related]
12. [Contribution of immunotyping in the diagnosis and in the prognosis of acute leukemia].
Merle-Béral H; Boucheix C
Rev Prat; 1996 Jan; 46(1):30-6. PubMed ID: 8596888
[TBL] [Abstract][Full Text] [Related]
13. Acute leukemia with natural killer cells antigens in Brazilian children.
Pombo-de-Oliveira MS; Campos MM; Bossa YE; Alencar DM; Curvello C; Agudelo DP; Mendonça N; Pereira E; Macedo-Silva ML
Leuk Lymphoma; 2004 Apr; 45(4):739-43. PubMed ID: 15160949
[TBL] [Abstract][Full Text] [Related]
14. Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.
Ludescher C; Eisterer W; Hilbe W; Gotwald M; Hofmann J; Zabernigg A; Cianfriglia M; Thaler J
Leukemia; 1995 Feb; 9(2):350-6. PubMed ID: 7869774
[TBL] [Abstract][Full Text] [Related]
15. Specific skin manifestations in CD56 positive acute myeloid leukemia.
Kuwabara H; Nagai M; Yamaoka G; Ohnishi H; Kawakami K
J Cutan Pathol; 1999 Jan; 26(1):1-5. PubMed ID: 10189238
[TBL] [Abstract][Full Text] [Related]
16. Definition of acute biphenotypic leukemia.
Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
[TBL] [Abstract][Full Text] [Related]
17. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
Babusíková O; Glasová M; Koníková E; Kusenda J
Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
[TBL] [Abstract][Full Text] [Related]
18. Numbers and cytotoxicities of CD3+CD56+ T lymphocytes in peripheral blood of patients with acute myeloid leukemia and acute lymphocytic leukemia.
Guo W; Xing C; Dong A; Lin X; Lin Y; Zhu B; He M; Yao R
Cancer Biol Ther; 2013 Oct; 14(10):916-21. PubMed ID: 24030391
[TBL] [Abstract][Full Text] [Related]
19. N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemia.
Coustan-Smith E; Behm FG; Hurwitz CA; Rivera GK; Campana D
Leukemia; 1993 Jun; 7(6):853-8. PubMed ID: 7684798
[TBL] [Abstract][Full Text] [Related]
20. Aberrant co-expression of CD19 and CD56 as surrogate markers of acute myeloid leukemias with t(8;21) in Taiwan.
Chen SW; Li CF; Chuang SS; Tzeng CC; Hsieh YC; Lee PS; Chen CH; Huang WT; Hwang WS; Tsao CJ
Int J Lab Hematol; 2008 Apr; 30(2):133-8. PubMed ID: 18333845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]